Literature DB >> 20628724

[Conventional and CT diagnostics of bronchial carcinoma].

C Schaefer-Prokop1.   

Abstract

A number of important technical advances made in recent years in the area of both digital radiography as well as multidetector computed tomography (MDCT) have improved detection and staging of bronchial carcinoma. The aim of elaborate processing such as temporal subtraction, rib suppression, dual energy subtraction or CAD is to aid the radiologist in detecting lung tumors at the earliest stage possible. For both CT and radiography techniques the differentiation between true and false positive lesions seems to be the biggest challenge. MDCT with multiplanar projections is the imaging method of choice for staging of the extent of local tumor spread (T staging), while N staging and M staging are the domain of positron emission tomography (PET) or even better of integrated PET/CT. Management rules for follow-up of solid and semi-solid lesions seen in CT consider the risks of the patient and are summarized in international guidelines. In 2009 a new 7th edition of the TNM classification was published, which, among other aspects, sub-classifies tumor size more specifically and the presence of a satellite nodule in the tumor lobe is down-staged to T3 and no longer determines tumor resectability. The N staging was not modified. One of the most important new features is the fact that the new classification no longer applies only to non-small cell lung cancer (NSCLC) but also to SCLC and carcinoid tumors.

Entities:  

Mesh:

Year:  2010        PMID: 20628724     DOI: 10.1007/s00117-009-1958-0

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  20 in total

Review 1.  A radiologic review of the new TNM classification for lung cancer.

Authors:  Seth Kligerman; Gerald Abbott
Journal:  AJR Am J Roentgenol       Date:  2010-03       Impact factor: 3.959

2.  Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.

Authors:  Heber MacMahon; John H M Austin; Gordon Gamsu; Christian J Herold; James R Jett; David P Naidich; Edward F Patz; Stephen J Swensen
Journal:  Radiology       Date:  2005-11       Impact factor: 11.105

Review 3.  CT, MR, and PET imaging in staging of non-small-cell lung cancer.

Authors:  Jeremy J Erasmus; Mylene T Truong; Reginald F Munden
Journal:  Semin Roentgenol       Date:  2005-04       Impact factor: 0.800

Review 4.  Management of an incidentally discovered pulmonary nodule.

Authors:  Catherine Beigelman-Aubry; Catherine Hill; Philippe A Grenier
Journal:  Eur Radiol       Date:  2006-10-05       Impact factor: 5.315

5.  Missed bronchogenic carcinoma: radiographic findings in 27 patients with a potentially resectable lesion evident in retrospect.

Authors:  J H Austin; B M Romney; L S Goldsmith
Journal:  Radiology       Date:  1992-01       Impact factor: 11.105

Review 6.  Computer-aided detection and automated CT volumetry of pulmonary nodules.

Authors:  Katharina Marten; Christoph Engelke
Journal:  Eur Radiol       Date:  2006-09-20       Impact factor: 5.315

7.  Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer.

Authors:  Tawee Tanvetyanon; Edward A Eikman; Eric Sommers; Lary Robinson; David Boulware; Gerold Bepler
Journal:  J Clin Oncol       Date:  2008-10-01       Impact factor: 44.544

8.  Lung cancer mortality in males screened by chest X-ray and cytologic sputum examination: a preliminary report.

Authors:  M L Levin; M S Tockman; J K Frost; W C Ball
Journal:  Recent Results Cancer Res       Date:  1982

9.  Temporal subtraction chest radiography.

Authors:  Heber MacMahon; Samuel G Armato
Journal:  Eur J Radiol       Date:  2009-07-05       Impact factor: 3.528

Review 10.  The revised TNM staging system for lung cancer.

Authors:  Ramon Rami-Porta; John J Crowley; Peter Goldstraw
Journal:  Ann Thorac Cardiovasc Surg       Date:  2009-02       Impact factor: 1.520

View more
  1 in total

1.  [Lung cancer staging].

Authors:  C Hintze; J Dinkel; J Biederer; C P Heussel; M Puderbach
Journal:  Radiologe       Date:  2011-02       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.